Rockville-based Emergent BioSolutions Inc. , which makes the only vaccine licensed by the Food and Drug Administration to protect against anthrax infection, has received FDA approval for a new, shorter-dosing schedule.
The new, supplemental biologics license application, follows trials to determine if the company's BioThrax vaccine would be effective with as few as three doses over six months.